مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

69
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

74
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

In vivo solid tumor targeting with recombinant VEGF-diphtheria immunotoxin

Pages

  27-31

Abstract

 Objective(s): A variety of signaling molecules have been identified that play a role in Angiogenesis, of prime importance, Vascular endothelial growth factor (VEGF) and its resceptor (VEGFR), which is highly expressed in most human solid Tumors. Targeting VEGF or/and VEGFR with Immunotoxin may be a promising approach to directly affect cancer cells. Immunotoxins are for targeted treatment comprising two functional moieties, an antibody that binds to target cells along with toxin that kills molecules. Materials and Methods: In this study, an Immunotoxin comprising domain of diphtheria toxin subunit A (DT386) genetically fused to mouse VEGF (mVEGF-DT) was developed. The second construct, which contains the DT386 domain, was made to investigate the action of the DT386 domain on Tumor cells. Both gene constructs were cloned, expressed, and were further purified. The biological activity of mVEGF-DT and DT386 proteins was assessed on the TC1 cell line bearing mouse model. Proteins were injected intra-Tumoral in mice, in separate groups. Results: Tumors in the mVEGF-DT group started to dwindle after six injections, but Tumor size in both control groups (DT386 and PBS), continued to grow. Conclusion: Successful targeting of solid Tumor cells by mVEGF-DT Immunotoxin demonstrates the therapeutic potential utility of these conjugates for Tumor targeting.

Multimedia

  • No record.

    • Cites

  • No record.

    • References

  • No record.

    • Cite

    APA: Copy

    HOSSEININEJAD CHAFI, MOHAMMAD, Alirahimi, Ehsan, Ramezani, Behzad, OGHALAIE, AKBAR, Sotoudeh, Nazli, Ghaderi, Hajarsadat, KAZEMI LOMEDASHT, FATEMEH, HABIBI ANBOUHI, MAHDI, Moazzami, Reza, & BEHDANI, MAHDI. (2022). In vivo solid tumor targeting with recombinant VEGF-diphtheria immunotoxin. IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 25(1), 27-31. SID. https://sid.ir/paper/984659/en

    Vancouver: Copy

    HOSSEININEJAD CHAFI MOHAMMAD, Alirahimi Ehsan, Ramezani Behzad, OGHALAIE AKBAR, Sotoudeh Nazli, Ghaderi Hajarsadat, KAZEMI LOMEDASHT FATEMEH, HABIBI ANBOUHI MAHDI, Moazzami Reza, BEHDANI MAHDI. In vivo solid tumor targeting with recombinant VEGF-diphtheria immunotoxin. IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES[Internet]. 2022;25(1):27-31. Available from: https://sid.ir/paper/984659/en

    IEEE: Copy

    MOHAMMAD HOSSEININEJAD CHAFI, Ehsan Alirahimi, Behzad Ramezani, AKBAR OGHALAIE, Nazli Sotoudeh, Hajarsadat Ghaderi, FATEMEH KAZEMI LOMEDASHT, MAHDI HABIBI ANBOUHI, Reza Moazzami, and MAHDI BEHDANI, “In vivo solid tumor targeting with recombinant VEGF-diphtheria immunotoxin,” IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, vol. 25, no. 1, pp. 27–31, 2022, [Online]. Available: https://sid.ir/paper/984659/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button